Company Filing History:
2 out of 5,469 
1 out of 850 
1 out of 1 Years Active: 2009-2010
Title: W Fraser Symmans: Innovator in Cancer Detection and Treatment
Introduction
W Fraser Symmans is a notable inventor based in Houston, TX, who has made significant strides in the field of oncology through his innovative methods for cancer detection and patient care. With two patents to his name, his work focuses on improving the survivability and treatment efficacy for breast cancer patients.
Latest Patents
Symmans' latest contributions to the field include two patents that serve as critical advancements in cancer therapy:
1. **Method of measuring residual cancer and predicting patient survival**: This method involves determining a residual cancer burden index by assessing various factors such as the bidimensional diameters of a primary tumor, the proportion of the tumor bed area containing invasive carcinoma, the number of positive regional lymph nodes, the size of the largest metastasis, and the reduction in lymph node size with each additional positive lymph node. This innovative approach helps in predicting patient outcomes during cancer treatment.
2. **Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer**: This invention encompasses compositions and kits specifically designed for the detection and treatment of breast cancer. It introduces newly identified markers that correlate changes in expression levels with the presence of breast cancer, thereby aiding in early diagnosis and targeted therapy.
Career Highlights
Throughout his career, W Fraser Symmans has contributed his expertise to several prestigious organizations. He has worked with Millennium Pharmaceuticals Limited, where he honed his skills in the pharmaceutical field, and the University of Texas System, contributing to academic research in cancer treatments. His career is marked by a commitment to enhancing patient outcomes through innovative medical solutions.
Collaborations
Symmans has collaborated with distinguished professionals in the field, including Lajos Pusztai and Mark David Ayers. These partnerships have fostered advancements in cancer research and have played a role in shaping his impactful inventions.
Conclusion
W Fraser Symmans exemplifies the spirit of innovation in the medical field, particularly in oncology. His groundbreaking patents demonstrate his dedication to improving cancer detection and treatment, ultimately striving to enhance patient survival rates. As he continues to innovate, the medical community eagerly anticipates the potential impact of his future contributions.